Table 3 Distribution of receptor status, age and tumor grade for breast cancers diagnosed in Botswana between 2011 and 2015 by HIV status
Clinicopathological features | HIV-uninfected (n = 65) n (%) | HIV-infected (n = 49) n (%) | p value |
|---|---|---|---|
Age |  |  | p < 0.0001 |
  < 50 | 15 (23.0) | 30 (61.2) |  |
  ≥ 50 | 48 (73.8) | 14 (28.6) |  |
Unspecified | 2 (3.1) | 5 (10.2) | Â |
Receptor Status |  |  | p = 0.513 |
 ER+ or PR+ or both, HER2- | 28 (43.1) | 24 (48.9) |  |
 ER+ or PR+ or both, HER2+ | 6 (9.2) | 5 (10.2) |  |
 HER2 enriched | 1 (1.5) | 4 (8.2) |  |
 Triple Negative | 4 (6.5) | 5 (10.2) |  |
 Missing | 26 (40.0) | 11 (22.4) |  |
Histologic Grade |  |  | p = 0.481 |
 Grade 1 | 9 (13.8) | 11 (22.4) |  |
 Grade 2 | 25 (38.4) | 24 (48.9) |  |
 Grade 3 | 16 (24.6) | 8 (16.3) |  |
 Missing/Unspecified | 15 (23.0) | 6 (12.2) |  |